Kenneth E. Hung

6.4k total citations · 2 hit papers
55 papers, 3.2k citations indexed

About

Kenneth E. Hung is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Kenneth E. Hung has authored 55 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Oncology and 22 papers in Genetics. Recurrent topics in Kenneth E. Hung's work include Inflammatory Bowel Disease (17 papers), Colorectal Cancer Treatments and Studies (12 papers) and Microscopic Colitis (10 papers). Kenneth E. Hung is often cited by papers focused on Inflammatory Bowel Disease (17 papers), Colorectal Cancer Treatments and Studies (12 papers) and Microscopic Colitis (10 papers). Kenneth E. Hung collaborates with scholars based in United States, Poland and Italy. Kenneth E. Hung's co-authors include Drew M. Pardoll, Hyam I. Levitsky, Robert J. Hayashi, Charles J. Lowenstein, Anne Lafond-Walker, Erin M. Coffee, Jeffrey A. Engelman, Jennifer A. Wargo, Keith T. Flaherty and Alexandria P. Cogdill and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Kenneth E. Hung

53 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Central Role of CD4+ T Cells in the Antitumor Immune Response

1998 1.1k citations Kenneth E. Hung, Drew M. Pardoll et al. profile →
EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

2012 767 citations Ryan B. Corcoran, Hiromichi Ebi et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth E. Hung United States	21	1.5k	1.3k	1.2k	476	338	55	3.2k
Alexandria P. Cogdill United States	12	2.8k 1.8×	1.6k 1.2×	1.4k 1.2×	347 0.7×	308 0.9×	15	3.7k
János L. Tanyi United States	36	1.7k 1.1×	1.9k 1.4×	887 0.7×	189 0.4×	720 2.1×	113	3.9k
Marion Dorsch United States	32	1.2k 0.8×	2.2k 1.7×	889 0.8×	202 0.4×	591 1.7×	55	3.7k
Begonya Comin-Anduix United States	28	2.6k 1.7×	1.7k 1.3×	2.1k 1.7×	220 0.5×	338 1.0×	42	4.3k
Markus Müschen United States	40	1.1k 0.7×	2.0k 1.5×	1.1k 0.9×	702 1.5×	493 1.5×	165	4.3k
Michael Hölzel Germany	33	1.7k 1.1×	2.2k 1.7×	1.3k 1.1×	214 0.4×	588 1.7×	96	4.3k
Hans Morreau Netherlands	33	1.5k 1.0×	1.7k 1.3×	651 0.6×	538 1.1×	835 2.5×	77	3.9k
Lindy G. Durrant United Kingdom	40	2.0k 1.3×	1.9k 1.4×	2.7k 2.3×	246 0.5×	338 1.0×	157	4.7k
Amod A. Sarnaik United States	34	3.0k 1.9×	1.6k 1.2×	1.8k 1.5×	174 0.4×	246 0.7×	129	4.3k
Marco de Bruyn Netherlands	30	1.7k 1.1×	986 0.7×	1.7k 1.5×	350 0.7×	440 1.3×	77	3.3k

Countries citing papers authored by Kenneth E. Hung

Since Specialization

Citations

This map shows the geographic impact of Kenneth E. Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth E. Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth E. Hung more than expected).

Fields of papers citing papers by Kenneth E. Hung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth E. Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth E. Hung. The network helps show where Kenneth E. Hung may publish in the future.

Co-authorship network of co-authors of Kenneth E. Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth E. Hung. A scholar is included among the top collaborators of Kenneth E. Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth E. Hung. Kenneth E. Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jairath, Vipul, Jessica R. Allegretti, Andrés Yarur, et al.. (2025). OP39 Treatment with RO7790121 induces and maintains histologic and histologic-endoscopic improvement and remission in moderately to severely active ulcerative colitis – Results from TUSCANY-2. Journal of Crohn s and Colitis. 19(Supplement_1). i75–i76. 1 indexed citations

Allegretti, Jessica R., Stefan Schreiber, Laurent Peyrin‐Biroulet, et al.. (2025). Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial. The Lancet. Gastroenterology & hepatology. 10(10). 882–895.

Vermeire, Séverine, Jessica R. Allegretti, Millie D. Long, et al.. (2024). OP09 Oral ritlecitinib and brepocitinib in patients with moderate to severe active Crohn’s Disease: Data from the PIZZICATO umbrella study. Journal of Crohn s and Colitis. 18(Supplement_1). i16–i16. 3 indexed citations

Hassan‐Zahraee, Mina, Zhan Ye, Xi Li, et al.. (2023). Baseline Serum and Stool Microbiome Biomarkers Predict Clinical Efficacy and Tissue Molecular Response After Ritlecitinib Induction Therapy in Ulcerative Colitis. Journal of Crohn s and Colitis. 18(9). 1361–1370. 7 indexed citations

Danese, Silvio, Maria Kłopocka, Ellen Scherl, et al.. (2021). Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study. Clinical Gastroenterology and Hepatology. 19(11). 2324–2332.e6. 60 indexed citations

Lau, Allison N., William J. Israelsen, Jatin Roper, et al.. (2017). PKM2 is not required for colon cancer initiated by APC loss. SHILAP Revista de lepidopterología. 5(1). 10–10. 37 indexed citations

Hung, Kenneth E., James C. Fleet, Roderick T. Bronson, et al.. (2014). Colon-specific tumorigenesis in mice driven by Cre-mediated inactivation of Apc and activation of mutant Kras. Cancer Letters. 347(2). 191–195. 18 indexed citations

Coffee, Erin M., Anthony C. Faber, Jatin Roper, et al.. (2013). Concomitant BRAF and PI3K/mTOR Blockade Is Required for Effective Treatment of BRAFV600E Colorectal Cancer. Clinical Cancer Research. 19(10). 2688–2698. 70 indexed citations

Corcoran, Ryan B., Hiromichi Ebi, Alexa B. Turke, et al.. (2012). EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib. Cancer Discovery. 2(3). 227–235. 767 indexed citations breakdown →

10.

Roper, Jatin & Kenneth E. Hung. (2012). Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development. Trends in Pharmacological Sciences. 33(8). 449–455. 32 indexed citations

11.

Chan, Andrew T., Yoshifumi Baba, Kaori Shima, et al.. (2010). Cathepsin B Expression and Survival in Colon Cancer: Implications for Molecular Detection of Neoplasia. Cancer Epidemiology Biomarkers & Prevention. 19(11). 2777–2785. 48 indexed citations

12.

Hung, Kenneth E. & Kenneth H. Yu. (2009). Proteomic Approaches to Cancer Biomarkers. Gastroenterology. 138(1). 46–51.e1. 17 indexed citations

13.

Chan, Err–Cheng, et al.. (2009). Cytotoxic Effect of Recombinant Mycobacterium tuberculosis CFP‐10/ESAT‐6 Protein on the Crucial Pathways of WI‐38 Cells. BioMed Research International. 2009(1). 917084–917084. 9 indexed citations

14.

Zhang, Qing, Rajasree Menon, Eric W. Deutsch, et al.. (2008). A mouse plasma peptide atlas as a resource for disease proteomics. Genome biology. 9(6). R93–R93. 18 indexed citations

15.

Forrester, Sara, Kenneth E. Hung, Rork Kuick, Raju Kucherlapati, & Brian B. Haab. (2007). Low‐volume, high‐throughput sandwich immunoassays for profiling plasma proteins in mice: Identification of early‐stage systemic inflammation in a mouse model of intestinal cancer. Molecular Oncology. 1(2). 216–225. 29 indexed citations

16.

Hung, Kenneth E. & Daniel C. Chung. (2006). Colorectal Cancer Screening: Today and Tomorrow. Southern Medical Journal. 99(3). 240–246. 6 indexed citations

17.

Chang, Edwin Y., Chien‐Hung Chen, Hongxiu Ji, et al.. (2000). Antigen‐specific cancer immunotherapy using a GM‐CSF secreting allogeneic tumor cell‐based vaccine. International Journal of Cancer. 86(5). 725–730. 7 indexed citations

18.

Chang, Edwin Y., Chien‐Hung Chen, Hongxiu Ji, et al.. (2000). Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine. International Journal of Cancer. 86(5). 725–730. 62 indexed citations

19.

Dawson, Ted M., Kenneth E. Hung, Valina L. Dawson, Joseph Steiner, & Solomon H. Snyder. (1995). Neuroprotective effects of gangliosides may involve inhibition of nitric oxide synthase. Annals of Neurology. 37(1). 115–118. 60 indexed citations

20.

Betageri, G. V., et al.. (1990). Effect of dipyridamole on transport and phosphorylation of thymidine and 3′-azido-3′-deoxythymidine in human monocyte/macrophages. Biochemical Pharmacology. 40(4). 867–870. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact